SpectraScience Inc SCIE:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 04/19/24 EDT
0.00UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date10/24/23
  • 52 Week Low0.00
  • 52 Week Low Date04/19/24

Key Stats

  • Market Cap4,823.924
  • Shares Out4.82B
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-7.55
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date10/24/23
  • 52 Week Low0.00
  • 52 Week Low Date04/19/24
  • Market Cap4,823.924
  • Shares Out4.82B
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-7.55
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.00
  • P/E (TTM)-0.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-1.994M
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-4,627.14%
  • Net Margin (TTM)-108,977.10%
  • Debt To Equity (MRQ)-60.90%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On SpectraScience Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
SpectraScience, Inc. is focused on developing its WavSTAT Optical Biopsy System (WavSTAT). The WavSTAT employs a risk technology that optically illuminates tissue in real-time to distinguish between normal and pre-cancerous or cancerous tissue. The Company has developed a technology platform to determine if tissue is normal, pre-cancerous or cancerous, without the need for a physical biopsy. The WavSTAT4 Optical Biopsy System operates by using cool, safe ultraviolet (UV)...
Mark McWilliams
Independent Chairman of the Board
Michael Oliver
President, Chief Executive Officer, Director
Lowell Giffhorn
Chief Financial Officer, Secretary
Address
11568 Sorrento Valley Road, Suite 11
San Diego, CA
92121
United States